Trial Profile
The Effect of Food on the Bioavailability of Merestinib in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Merestinib (Primary)
- Indications Biliary cancer; Cancer
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 25 Aug 2016 Status changed from not yet recruiting to completed.
- 24 May 2016 New trial record